Funding · Climate, Energy & Sustainability

Intrinsic Foundries raises ₹12 crore seed round

By Startup Enthusiast · 9 February 2026

What they do

Intrinsic Foundries turns industrial waste gases, liquids and solids into premium biochemicals

It raised ₹12 crore ($1.4 million) in seed funding led by Transition VC

The company will use the funds to run industrial pilots and expand its research and engineering teams

Intrinsic Foundries raised ₹12 crore ($1.4 million) in a seed round.
Transition VC led the seed round.
The company is a carbon-to-value biomanufacturing platform.
It turns industrial waste gases, liquids and solids into premium biochemicals.
It uses proprietary microbial biorefinery, modular photobioreactors and integrated automation.
The company was founded in 2023 by Shreyansh Jain, Sanjay Jain and Umang Jain.

India committed ₹20,000 crore (~$2.4 billion) over five years in the recent budget to scale CCUS (carbon capture, utilisation and storage).
Transition VC partner Shantanu Chaturvedi said CCUS adoption is constrained by poor unit economics and high capital expenditure.
Intrinsic captures CO2 from industrial sources using microalgae upstream and converts it to high-value biochemicals for pharma, nutraceutical and cosmetic industries.
Founder Shreyansh Jain said carbon is a resource, not waste, and the company uses nature-based biological systems to turn industrial emissions into ingredients for supplements, food and skincare.

Intrinsic Foundries is a carbon-to-value biomanufacturing platform.
It turns industrial waste gases, liquids and solids into premium biochemicals.
It uses proprietary microbial biorefinery, modular photobioreactors and integrated automation.
The company targets the pharma, nutraceutical and cosmetic industries with its biochemical products.
It has strategic R&D partnerships in the US and Germany with process engineers, scientists and automation specialists.

Use funds to execute industrial pilots, expand research and file IPs.
Scale engineering and commercial teams, strengthen manufacturing and establish a US entity for global market development.
In the next 12-24 months, commission multiple industrial pilots and start the first one-ton-per-day commercial plant.
Grow the patent portfolio, earn cumulative revenue from pilots and biochemical products, and expand international market access.
Long-term goal: make carbon-to-value biomanufacturing infrastructure a foundation of global industrial decarbonisation.

Transition VC (lead) — A venture capital firm investing in climate and sustainability startups.

Product: Microbial biorefinery systems and modular photobioreactors converting industrial emissions and residues into biochemicals
Customers: Food, pharmaceutical, nutraceutical, cosmetic, agricultural and advanced materials industries
How it makes money: B2B supply of sustainable biochemical ingredients with revenue from carbon credits and product sales
What sets it apart: Scalable revenue-positive decarbonization transforming emissions into essential product inputs